JCARH125, Anti-BCMA CAR T-cell Therapy for Relapsed/Refractory Multiple Myeloma: Initial Proof of Concept Results from a Phase 1/2 Multicenter Study (EVOLVE)

被引：82

作者：

Mailankody, Sham ^{[1
]}

Htut, Myo ^{[2
]}

Lee, Kelvin P. ^{[3
]}

Bensinger, William ^{[4
]}

Devries, Todd ^{[5
]}

Piasecki, Julia ^{[5
]}

Ziyad, Safiyyah ^{[5
]}

Blake, Michelle ^{[5
]}

Byon, John ^{[5
]}

Jakubowiak, Andrzej ^{[5
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[2] City Hope Med Ctr, Judy & Bernard Briskin Ctr Multiple Myeloma Res, Duarte, CA USA

[3] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[4] Swedish Canc Inst, Ctr Blood Disorders & Stem Cell Transplantat, Seattle, WA USA

[5] Juno Therapeut, Seattle, WA USA

来源：

关键词：

D O I：

10.1182/blood-2018-99-113548

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

957

引用

页数：2